Medtronic received information that post - implant, the patient returned to the operating room for chest exploration and hematoma evacuation due to mediastinal bleeding.Hemostasis was achieved prior to chest tube replacement and sternal closure.The patient received a transfusion of one unit of packed red blood cells; the patient received 233 ml of blood via cell saver.No further adverse patient effects were reported.(b)(4).This report reflects information received by fda in the form of a notification per 803.22 (b)(2).
|